4.8 Article

Sliding-strip microfluidic device enables ELISA on paper

期刊

BIOSENSORS & BIOELECTRONICS
卷 99, 期 -, 页码 77-84

出版社

ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2017.07.034

关键词

Resource-limited; C-reactive protein; Blood; Sepsis; Inflammatory bowel diseases; Receiver operator characteristics

资金

  1. Bill and Melinda Gates Foundation [51308]
  2. Defense Threat Reduction Agency [HDTRA1-14-C-0037]
  3. Government of Canada
  4. International Outgoing Marie Curie Fellowship [IOF-GA-2013-622879-ENVIRO]
  5. Summer Research Experience for Undergraduates of the Harvard Materials Research Science and Engineering Center (MRSEC REU)
  6. Harvard College Research Program (HCRP)
  7. Fonds de Recherche Nature et Technologies
  8. Direct For Mathematical & Physical Scien
  9. Division Of Materials Research [1559890] Funding Source: National Science Foundation

向作者/读者索取更多资源

This article describes a 3D microfluidic paper-based analytical device that can be used to conduct an enzyme linked immunosorbent assay (ELISA). The device comprises two parts: a sliding strip (which contains the active sensing area) and a structure surrounding the sliding strip (which holds stored reagents-buffers, antibodies, and enzymatic substrate-and distributes fluid). Running an ELISA involves adding sample (e.g. blood) and water, moving the sliding strip at scheduled times, and analyzing the resulting color in the sensing area visually or using a flatbed scanner. We demonstrate that this device can be used to detect C-reactive protein (CRP)-a biomarker for neonatal sepsis, pelvic inflammatory disease, and inflammatory bowel diseases-at a concentration range of 1-100 ng/mL in 1000-fold diluted blood (1-100 mu g/mL in undiluted blood). The accuracy of the device (as characterized by the area under the receiver operator characteristics curve) is 89% and 83% for cutoffs of 10 ng/mL (for neonatal sepsis and pelvic inflammatory disease) and 30 ng/mL (for inflammatory bowel diseases) CRP in 1000-fold diluted blood respectively. In resource-limited settings, the device can be used as a part of a kit (containing the device, a fixed-volume capillary, a pre-filled tube, a syringe, and a dropper); this kit would cost similar to $0.50 when produced in large scale (>100,000 devices/week). This kit has the technical characteristics to be employed as a pre-screening tool, when combined with other data such as patient history and clinical signs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据